Join us for a special Thirsty Thursday hosted by Mission BioCapital to learn about the Platinum Program. This initiative in collaboration with Eli Lilly, Ono Venture Investment, Alloy Therapeutics, HitGen, Goodwin, and van den Boom & Associates awards up to $500,000 per company for early-stage life sciences entrepreneurs. Enjoy a wine and cheese reception, learn about the program, and how to apply successfully. Stick around for tours of our newly opened facility just next door!
About the program
The Mission BioCapital Platinum Program is an initiative designed to support early-stage life sciences entrepreneurs in launching and developing transformative biotech startups. Established in 2022, the program provides comprehensive resources to help founders overcome common challenges in biotechnology innovation, such as securing funding and laboratory space.
Key Benefits to Entrepreneurs
Participants in the Platinum Program receive:
- Seed Capital: Up to $500,000 per company. Funding is provided as a SAFE.
- Laboratory Space: Guaranteed lab benches in one of Mission BioCapital’s affiliated incubators located across 15 cities in the U.S. and Europe, including San Francisco and San Carlos.
- Drug Discovery Services: Access to cutting-edge discovery services from partners like Alloy Therapeutics and HitGen.
- Mentorship: Strategic scientific and business development guidance from experts across Mission BioCapital’s corporate network, including sponsors Eli Lilly and Ono Venture Investment.
- Operational Support: Assistance with legal advising, intellectual property management, accounting services, company incorporation, and technology licensing from Goodwin and van den Boom & Associates.
Since its inception, the Platinum Program has supported 16 startups with $7.5 million in funding, laboratory space, and mentorship. These companies are advancing innovations such as novel therapeutics for neurodegeneration and synthetic biology-driven treatments for cellular stress responses. The program aims to foster exceptional founders and accelerate biomedical breakthroughs to address unmet medical needs worldwide.